Andra AP fonden Acquires New Shares in Vertex Pharmaceuticals

The institutional investor bought 35,900 shares of the pharmaceutical company's stock, valued at approximately $14,060,000.

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

Andra AP fonden, an institutional investor, bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The investor purchased 35,900 shares of the pharmaceutical company's stock, valued at around $14,060,000.

Why it matters

Vertex Pharmaceuticals is a leading biotechnology company focused on developing treatments for serious diseases, particularly cystic fibrosis. The acquisition of new shares by Andra AP fonden, a major institutional investor, suggests confidence in the company's future prospects and growth potential.

The details

Andra AP fonden bought the new position in Vertex Pharmaceuticals during the third quarter of the year. The 35,900 shares purchased are valued at approximately $14,060,000. This investment adds to Andra AP fonden's existing portfolio and reflects the investor's belief in Vertex's ability to continue its success in the pharmaceutical industry.

  • Andra AP fonden bought the new position in Vertex Pharmaceuticals during the 3rd quarter of 2026.

The players

Andra AP fonden

An institutional investor that bought a new position in Vertex Pharmaceuticals Incorporated.

Vertex Pharmaceuticals Incorporated

A Boston-based biotechnology company focused on the discovery, development and commercialization of therapies for serious diseases, particularly cystic fibrosis.

Got photos? Submit your photos here. ›

The takeaway

Andra AP fonden's acquisition of new shares in Vertex Pharmaceuticals reflects the investor's confidence in the company's future growth and ability to continue its success in the pharmaceutical industry, particularly in the development of treatments for serious diseases like cystic fibrosis.